149 related articles for article (PubMed ID: 3491710)
1. An efficient one-step method for isolating immune complexes from whole serum using a monoclonal anti-C3g affinity immunosorbent.
Samuel DJ; Amlot PL; Shepherd P; Lachmann PJ
Clin Exp Immunol; 1986 Aug; 65(2):458-64. PubMed ID: 3491710
[TBL] [Abstract][Full Text] [Related]
2. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
3. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
Larsson A; Jonsson L; Sjöquist J
J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
[TBL] [Abstract][Full Text] [Related]
4. Serum and plasma fibronectin binds to complement reacted immune complexes primarily via Clq.
Baatrup G; Svehag SE
Scand J Immunol; 1986 Nov; 24(5):583-90. PubMed ID: 3097811
[TBL] [Abstract][Full Text] [Related]
5. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
6. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
7. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
Bindon CI; Hale G; Brüggemann M; Waldmann H
J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
[TBL] [Abstract][Full Text] [Related]
9. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
Soltis RD; Hasz DE
J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
[TBL] [Abstract][Full Text] [Related]
10. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
Baatrup G; Svehag SE; Jensenius JC
Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel C1q immunoadsorbent for removal of circulating immunecomplexes: quantitative isolation of hepatitis B virus surface antigen and immunecomplexes.
Gazitt Y; Margel S; Lerner A; Wands JR; Shouval D
Immunol Lett; 1985; 11(1):1-8. PubMed ID: 3876986
[TBL] [Abstract][Full Text] [Related]
12. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
13. Problems in the detection of complement-fixing immune complexes.
Rødahl E
Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
[TBL] [Abstract][Full Text] [Related]
14. Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.
Smith AJ; Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1987 Jun; 46(6):468-74. PubMed ID: 2820320
[TBL] [Abstract][Full Text] [Related]
15. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
[TBL] [Abstract][Full Text] [Related]
16. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
17. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
18. Interaction of C1q subcomponent with immunoglobulin M.
Kimak E; Tomaszewski JJ
Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
[TBL] [Abstract][Full Text] [Related]
19. The use of C1q, conglutinin and low affinity rabbit IgM antibody to human Fc in a ligand coctail radioassay for detecting and characterizing immune complexes in pathological sera.
Harkiss GD; Brown DL
Clin Exp Immunol; 1980 Mar; 39(3):576-82. PubMed ID: 7379330
[TBL] [Abstract][Full Text] [Related]
20. Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients.
Moore TL; Dorner RW
Rheumatol Int; 1986; 6(2):49-52. PubMed ID: 3532285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
